bioAffinity Technologies (BIAF) vs IQVIA (IQV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
IQVIA is the larger company by market cap ($42.78 billion vs $5.5 million), about 7760.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BIAF | IQV |
|---|---|---|
| Share price | $4.73 | $259.88 |
| Market cap | $5.51M | $42.78B |
| 1-day change | -16.22% | +0.39% |
| YTD return | — | +14.85% |
| 1-year return | — | +29.05% |
| 5-year return | — | +4.03% |
| P/E ratio (TTM) | — | 32.28 |
| Forward P/E | — | 18.01 |
| EPS (TTM) | $-109.35 | $8.05 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $16.31B |
| Revenue growth (YoY) | — | +5.87% |
| Net income (latest FY) | — | $1.36B |
| Gross margin | — | 33.29% |
| Operating margin | — | 13.38% |
| Net margin | — | 8.34% |
| 52-week high | $80.70 | $277.40 |
| 52-week low | $4.56 | $154.50 |
| Distance from 52-week high | -94.14% | -6.32% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +11.91% |
| Average volume | 3.67M | 1.45M |
| Shares outstanding | 1.17M | 164.60M |
| Employees | 57 | 94,000 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Commercial Physical & Biological Resarch |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- IQVIA is about 7760.1 times larger than bioAffinity Technologies by market value ($42.78B vs $5.51M).
About bioAffinity Technologies
BIAF stock →bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 57 employees
About IQVIA
IQV stock →IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 94,000 employees
BIAF vs IQV FAQ
Which is bigger, bioAffinity Technologies or IQVIA?
IQVIA (IQV) is larger, with a market capitalization of $42.78B compared with $5.51M for bioAffinity Technologies (BIAF).
Are bioAffinity Technologies and IQVIA in the same industry?
Yes. Both are classified in the Biotechnology: Commercial Physical & Biological Resarch industry within the Health Care sector.